MINNEAPOLIS--(BUSINESS WIRE)--Flywheel, the leading biomedical research data management platform, today announces the acquisition of St. Louis-based Radiologics. The two organizations’ combined capabilities in imaging research data management and analytics provide the medical research community unrivaled end-to-end research workflow solutions—from open source to global enterprise. Together, the two companies, now operating as Flywheel, offer the only biomedical research platform that can connect any organization or data set across academia, life sciences, clinical, and medical AI.
“Big data plays a pivotal role in healthcare innovation. And realizing the full potential of innovation requires better data management,” said Jim Olson, Flywheel CEO. “The combined Flywheel and Radiologics capabilities uniquely enable increased collaboration among the brightest scientific and medical minds and the best data sets in the industry, making it possible for the smallest labs to collaborate with the largest academic medical centers and commercial enterprises. Our goal is to power accelerated R&D in oncology, radiology and other therapeutic areas where innovation is paramount and increasingly data-driven.”
Flywheel will now offer:
- Cross-platform data and algorithm interoperability.
- An accelerated roadmap of new features and tools.
- An expanded network with more opportunities for research collaboration.
- Secure and compliant data discovery across a global network of opted-in innovators.
- Cloud-scalable and on-premise computational workflows for research and clinical applications.
“Together, we’re going to help speed the development of clinical trials, get to discovery faster, and reduce wasted time and resources along the way. We understood the tremendous opportunity to bring together Flywheel’s and Radiologics’ expertise for the advancement of medical research,” said Dan Marcus, PhD, Radiologics CEO, who will take on the role of Chief Scientific Officer at Flywheel. “I’m thrilled that our combined company will continue to serve the research community through open source and enterprise informatics solutions.”
“I am incredibly excited about the news that Flywheel and Radiologics are joining forces. This opens up a lot of opportunities for our MRI Unit and Department of Psychiatry to more seamlessly collaborate with other departments at Columbia, as well as outside the institution,” said Rachel Marsh, PhD, Irving Philips Professor of Medical Psychology at Columbia University Irving Medical Center, and Director of the MRI Research Program at the New York State Psychiatric Institute. “I look forward to being able to access the combined expertise of both Flywheel and Radiologics and to being part of their extensive network of researchers who can now more easily work together on a common platform to drive faster discovery.”
In addition to Flywheel’s cloud-based research data platform, the company will offer original Radiologics products and services—a full range of imaging informatics services around the XNAT platform, including consulting, technical support, software development, custom image processing pipelines, and staffing solutions.
“At the end of the day, we’re here to take care of the data, so researchers can focus on what matters most—science, innovation and creating life-changing therapies,” added Olson.
About Flywheel
Flywheel is the revolutionary research data management platform powering healthcare innovation by accelerating collaboration, enabling machine learning, and streamlining the massive task of data aggregation, curation and management. By leveraging cloud scalability and automating research workflows, Flywheel helps organizations scale research data and analysis, improve scientific collaboration and accelerate discoveries. Flywheel offers comprehensive solutions for life sciences, pharmaceutical, biotech, academic, and clinical research. Flywheel is headquartered in Minneapolis and has offices in the Bay Area, St. Louis, and Budapest. For more information, visit www.flywheel.io or follow us on LinkedIn and Twitter.